Literature DB >> 19204735

Effects of inoculating dose on the kinetics of Chlamydia muridarum genital infection in female mice.

Alison J Carey1, Kelly A Cunningham, Louise M Hafner, Peter Timms, Kenneth W Beagley.   

Abstract

Chlamydia trachomatis infections have been implicated in problems such as pelvic inflammatory disease and infertility in females. Although there are some studies examining the kinetics of ascending infection, there is limited information on the kinetics of pathology development and cellular infiltrate into the reproductive tissues in relation to the effects of inoculating dose, and a better understanding of these is needed. The murine model of female genital tract Chlamydia muridarum infection is frequently used as a model of human C. trachomatis reproductive tract infection. To investigate the kinetics of ascending genital infection and associated pathology development, female BALB/c mice were intravaginally infected with C. muridarum at doses ranging from 5 x 10(2) to 2.6 x 10(6) inclusion forming units. We found that the inoculating dose affects the course of infection and the ascension of bacteria, with the highest dose ascending rapidly to the oviducts. By comparison, the lowest dose resulted in the greatest bacterial load in the lower reproductive tract. Interestingly, we found that the dose did not significantly affect inflammatory cell infiltrate in the various regions. Overall, this data show the effects of infectious dose on the kinetics of ascending chlamydial infection and associated inflammatory infiltration in BALB/c mice.

Entities:  

Mesh:

Year:  2009        PMID: 19204735     DOI: 10.1038/icb.2009.3

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  17 in total

Review 1.  Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.

Authors:  Christina M Farris; Richard P Morrison
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  Parenteral vaccination protects against transcervical infection with Chlamydia trachomatis and generate tissue-resident T cells post-challenge.

Authors:  Nina Dieu Nhien Tran Nguyen; Anja W Olsen; Emma Lorenzen; Peter Andersen; Malene Hvid; Frank Follmann; Jes Dietrich
Journal:  NPJ Vaccines       Date:  2020-01-23       Impact factor: 7.344

3.  Microbiological Characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in South African Women.

Authors:  Jan Henk Dubbink; Dewi J de Waaij; Myrte Bos; Lisette van der Eem; Cécile Bébéar; Nontembeko Mbambazela; Sander Ouburg; Remco P H Peters; Servaas A Morré
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

4.  Divergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigens.

Authors:  Charles W Armitage; Connor P O'Meara; Marina C G Harvie; Peter Timms; Richard S Blumberg; Kenneth W Beagley
Journal:  Immunol Cell Biol       Date:  2014-01-21       Impact factor: 5.126

5.  Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development.

Authors:  Wei He; Martina Felderman; Angela C Evans; Jia Geng; David Homan; Feliza Bourguet; Nicholas O Fischer; Yuanpei Li; Kit S Lam; Aleksandr Noy; Li Xing; R Holland Cheng; Amy Rasley; Craig D Blanchette; Kurt Kamrud; Nathaniel Wang; Heather Gouvis; Todd C Peterson; Bolyn Hubby; Matthew A Coleman
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

6.  Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NFκB activation resulting in a microenvironment predisposed to ectopic pregnancy.

Authors:  Julie L V Shaw; Gillian S Wills; Kai-Fai Lee; Paddy J Horner; Myra O McClure; Vikki M Abrahams; Nick Wheelhouse; Henry N Jabbour; Hilary O D Critchley; Gary Entrican; Andrew W Horne
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  In vivo whole animal body imaging reveals colonization of Chlamydia muridarum to the lower genital tract at early stages of infection.

Authors:  Rishein Gupta; Shradha Wali; Jieh-Juen Yu; James P Chambers; Guangming Zhong; Ashlesh K Murthy; Sazaly Abu Bakar; M N Guentzel; Bernard P Arulanandam
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

8.  Induction of partial immunity in both males and females is sufficient to protect females against sexual transmission of Chlamydia.

Authors:  C P O'Meara; C W Armitage; A Kollipara; D W Andrew; L Trim; M B Plenderleith; K W Beagley
Journal:  Mucosal Immunol       Date:  2015-12-09       Impact factor: 7.313

9.  Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response.

Authors:  Rishein Gupta; Tanvi Arkatkar; Jieh-Juen Yu; Shradha Wali; William E Haskins; James P Chambers; Ashlesh K Murthy; Sazaly Abu Bakar; M Neal Guentzel; Bernard P Arulanandam
Journal:  Am J Reprod Immunol       Date:  2014-06-28       Impact factor: 3.886

10.  Chlamydia trachomatis load in population-based screening and STI-clinics: implications for screening policy.

Authors:  Jeanne A M C Dirks; Petra F G Wolffs; Nicole H T M Dukers-Muijrers; Antoinette A T P Brink; Arjen G C L Speksnijder; Christian J P A Hoebe
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.